Scholarlink

Background <p>The aim of this nationwide survey was to assess the current organizational structures and utilization patterns of temporary right ventricular assist devices (tRVAD) for the treatment of acute right ventricular failure (RVF) in Germany.</p> Methods <p>Between March and June 2025, a&#xa0;standardized 18-item questionnaire focusing on the diagnosis, indications and management of RVF and tRVAD was distributed to all 86&#xa0;cardiovascular surgery departments in Germany.</p> Results <p>Of the 86&#xa0;centers contacted 48 (55.8%) responded. The data reveal that specialized tRVAD experience is concentrated; only 20.8% of clinics use tRVAD more than 10&#xa0;times a&#xa0;year. While post-LVAD RVF was identified as a&#xa0;frequent indication (particularly in high-volume centers, <i>p</i> = 0.016), va-extracorporeal membrane oxygenation (ECMO) remains the most commonly used system (87.5%). The use of specialized systems such as Impella RP (<i>p</i> = 0.034) and TandemHeart (<i>p</i> = 0.010) was significantly more frequent in high-volume centers.</p> Conclusion <p>This nationwide survey highlights a&#xa0;significant disparity in tRVAD utilization across German centers. While va-ECMO remains the clinical standard, advanced percutaneous systems are predominantly confined to high-volume centers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Einsatz von temporären RVAD-Systemen in Deutschland – Ergebnisse einer Umfrage in herzchirurgischen Kliniken

  • 期刊论文

  • 发表日期：

    2026年7月10日

查看全文
  • Mehmet Oezkur,
  • Alexander Assmann,
  • Udo Boeken,
  • Andreas Beckmann

摘要

Background

The aim of this nationwide survey was to assess the current organizational structures and utilization patterns of temporary right ventricular assist devices (tRVAD) for the treatment of acute right ventricular failure (RVF) in Germany.

Methods

Between March and June 2025, a standardized 18-item questionnaire focusing on the diagnosis, indications and management of RVF and tRVAD was distributed to all 86 cardiovascular surgery departments in Germany.

Results

Of the 86 centers contacted 48 (55.8%) responded. The data reveal that specialized tRVAD experience is concentrated; only 20.8% of clinics use tRVAD more than 10 times a year. While post-LVAD RVF was identified as a frequent indication (particularly in high-volume centers, p = 0.016), va-extracorporeal membrane oxygenation (ECMO) remains the most commonly used system (87.5%). The use of specialized systems such as Impella RP (p = 0.034) and TandemHeart (p = 0.010) was significantly more frequent in high-volume centers.

Conclusion

This nationwide survey highlights a significant disparity in tRVAD utilization across German centers. While va-ECMO remains the clinical standard, advanced percutaneous systems are predominantly confined to high-volume centers.